Oncotarget

Corrections:

Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells

PDF  |  How to cite

Oncotarget. 2020; 11:3103-3104. https://doi.org/10.18632/oncotarget.27597

Metrics: PDF 321 views  |   ?  

Sham S. Kakar1,2, Seema Parte2, Kelsey Carter1, Irving G. Joshua1, Christopher Worth2, Pranela Rameshwar3 and Mariusz Z. Ratajczak4

1 Department of Physiology, University of Louisville, Louisville, KY 40202, USA
2 James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA
3 Department of Medicine, Hematology/Oncology, Rutgers, New Jersey Medical School, Newark, NJ 07103, USA
4 Department of Medicine, University of Louisville, Louisville, KY 40202, USA

Published: August 11, 2020

This article has been corrected: In Figure 3, panel F is an accidental duplicate of panel C. The corrected Figure 3 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:74494–74505. DOI: https://doi.org/10.18632/oncotarget.20170.

Figure 3: Effect of WFA and CIS both alone and in combination on spheroid formation. (A) - Control, (B) - WFA (0.5 μM), (C) - WFA (1.5 μM), (D) - CIS (20 μM), (E) - WFA (0.5 μM) + CIS (20 μM), and (F) - WFA (1.5 μM) + CIS (20 μM). i) Photomicrographs of spheroids under various treatment groups as described above. ii) Quantitative analysis of spheroids. Spheroids > 50 mm were counted. The number shown is average of spheroids counted in 6 different low power fields at 200X. Data shown is representative of three independent experiments. * represents p < 0.05.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27597